Stay updated on NILE Clinical Trial: Durvalumab Combo in Unresectable Urothelial Cancer

Sign up to get notified when there's something new on the NILE Clinical Trial: Durvalumab Combo in Unresectable Urothelial Cancer page.
Latest website image capture
Clouds background image

Latest updates to the NILE Clinical Trial: Durvalumab Combo in Unresectable Urothelial Cancer page

  1. Check
    4 days ago
    Change Detected
    Summary
    Revision: v3.6.3 was added and Revision: v3.6.2 was removed in the history. This represents a versioning update to the page history rather than a modification to trial data or core content.
    Difference
    0.0%
    Check dated 2026-07-05T14:30:31.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The page footer now shows Revision: v3.6.2, replacing the previous v3.6.0. This reflects a software update to the ClinicalTrials.gov interface and does not modify the study history data.
    Difference
    0.0%
    Check dated 2026-06-28T08:39:29.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The study history now shows that enrollment is closed (no longer looking for participants) and adds a new revision entry (v3.6.0), with the previous revision (v3.5.5) removed from the record.
    Difference
    0.2%
    Check dated 2026-06-13T17:05:26.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    A new site revision label v3.5.5 was added, replacing the previous v3.5.4 in the record history. This indicates a minor system or UI update and does not change study data or content.
    Difference
    0.0%
    Check dated 2026-06-06T13:36:03.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    Two new history entries were added: 2026-05-28 labeled 'Study Status' and 2026-05-27 showing '64'. The 2026-02-03 entry was removed.
    Difference
    0.2%
    Check dated 2026-05-30T12:07:46.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    The page’s revision tag has been updated to v3.5.4, indicating a new build. This reflects an incremental release rather than content changes.
    Difference
    0.0%
    Check dated 2026-05-15T23:52:41.000Z thumbnail image

Stay in the know with updates to NILE Clinical Trial: Durvalumab Combo in Unresectable Urothelial Cancer

Enter your email address, and we'll notify you when there's something new on the NILE Clinical Trial: Durvalumab Combo in Unresectable Urothelial Cancer page.